Holdings
State Street(R) Health Care Select Sector SPDR(R) ETF
As of Jun 30, 2026, State Street(R) Health Care Select Sector SPDR(R) ETF reported 59 positions worth US$40.5B. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 5.59M | US$6.7B | −178K | Jun 30, 2026 |
| Johnson & Johnson | 17M | US$4.32B | −531K | Jun 30, 2026 |
| Abbvie Inc. | 12.5M | US$3.14B | −380K | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 6.42M | US$2.67B | −176K | Jun 30, 2026 |
| Merck & Company, Inc. | 17.4M | US$2.24B | −613K | Jun 30, 2026 |
| Amgen Inc. | 3.81M | US$1.38B | −106K | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 2.63M | US$1.32B | −109K | Jun 30, 2026 |
| Abbott Laboratories | 12.3M | US$1.12B | −349K | Jun 30, 2026 |
| Gilead Sciences, Inc. | 8.77M | US$1.11B | −257K | Jun 30, 2026 |
| Intuitive Surgical, Inc. | 2.5M | US$995M | −82,245 | Jun 30, 2026 |